This engagement not only promotes the expression of pro-inflammatory cytokines and vascular endothelial growth factor (VEGF), which in turn facilitates angiogenesis within the tumor microenvironment (TME), but Fusobacterium nucleatum is also generally associated with worse clinical outcomes. Here, VEGFA is linked to neoplasm.